Overall rank by patents
#6,969
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
VERINATA HEALTH, INC.
USPTO PatentsView assignee record — 48 granted patents across 10 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
48
Total patents granted
10
CPC technology areas
23.5
Avg claims per patent
+18%
5-year filing velocity
Portfolio overview
VERINATA HEALTH, INC. has been granted 48 US utility patents between 2015 and 2025, placing VERINATA HEALTH, INC. at rank #6,969 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.5 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, VERINATA HEALTH, INC. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 43.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 26 grants, compared with 22 in the 2015–2019 window — a +18% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. VERINATA HEALTH, INC.'s 23.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark VERINATA HEALTH, INC. against peers pursuing similar technology classes.
How does VERINATA compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Verinata Health ◀ 48
VERINATA HEALTH, INC.
48 patents
What this shows VERINATA holds 48 patents — placing it at rank #6,969 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 4.2% |
| 2016 | 8 | 16.7% |
| 2017 | 2 | 4.2% |
| 2018 | 4 | 8.3% |
| 2019 | 6 | 12.5% |
| 2020 | 8 | 16.7% |
| 2021 | 3 | 6.3% |
| 2022 | 6 | 12.5% |
| 2023 | 3 | 6.3% |
| 2024 | 4 | 8.3% |
| 2025 | 2 | 4.2% |
Which technologies does VERINATA HEALTH, INC. patent most?
Top 10 of 10 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Growing
Frequently Asked Questions
How many patents does VERINATA HEALTH, INC. hold?
VERINATA HEALTH, INC. holds 48 US granted patents filed between 2015 and 2025, spanning 10 technology areas.
What is VERINATA HEALTH, INC.'s Innovation Score?
VERINATA HEALTH, INC. has an Innovation Score of 43.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does VERINATA HEALTH, INC. focus on?
VERINATA HEALTH, INC.'s top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 45 patents. The company has filed patents in 10 CPC subclasses total.
Is VERINATA HEALTH, INC.'s patent filing rate increasing or decreasing?
VERINATA HEALTH, INC.'s recent filing velocity is +18% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for VERINATA HEALTH, INC.'s patents?
VERINATA HEALTH, INC.'s patents average 23.5 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the VERINATA HEALTH, INC. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
C12Q technology
VERINATA HEALTH, INC.'s primary CPC class — all holders and yearly trends
Top 50 patent holders
See where VERINATA HEALTH, INC. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
